Determination of flurbiprofen in pharmaceutical preparations by GC-MS


YILMAZ B., Alkan E.

ARABIAN JOURNAL OF CHEMISTRY, cilt.12, sa.8, ss.2077-2083, 2019 (SCI-Expanded) identifier identifier

  • Yayın Türü: Makale / Tam Makale
  • Cilt numarası: 12 Sayı: 8
  • Basım Tarihi: 2019
  • Doi Numarası: 10.1016/j.arabjc.2014.12.038
  • Dergi Adı: ARABIAN JOURNAL OF CHEMISTRY
  • Derginin Tarandığı İndeksler: Science Citation Index Expanded (SCI-EXPANDED), Scopus
  • Sayfa Sayıları: ss.2077-2083
  • Anahtar Kelimeler: Flurbiprofen, Derivatization, Gas chromatography-mass spectrometry, Validation, Pharmaceutical tablet, PERFORMANCE LIQUID-CHROMATOGRAPHY, ANTIINFLAMMATORY AGENTS, ALZHEIMERS-DISEASE, HUMAN URINE, ASSAY, HPLC, VALIDATION, PLASMA, BIOAVAILABILITY, ENANTIOMERS
  • Atatürk Üniversitesi Adresli: Evet

Özet

This article describes a gas chromatography-mass spectrometry (GC-MS) method for the determination of flurbiprofen in pharmaceutical preparations. The method is based on the derivatization of flurbiprofen with N-methyl-N-(trimethylsilyl)trifluoroacetamide (MSTFA). For GC-MS, electron ionization mode (EI= 70 eV) and selected ion monitoring (SIM) mode were used for quantitative analysis (m/z 180 for flurbiprofen). Calibration curve was linear between the concentration range of 0.25-5.0 mu g/mL. Intra- and inter-day precision values for flurbiprofen were less than 3.64, and accuracy (relative error) was better than 2.67%. The mean recovery of flurbiprofen was 99.4% for pharmaceutical preparations. The limits of detection and quantification of flurbiprofen were 0.05 and 0.15 mu g/mL, respectively. No interference was found from tablet excipients at the selected assay conditions. Also, the method was applied for the quality control of five commercial flurbiprofen dosage forms to quantify the drug and to check the formulation content uniformity. (C) 2015 The Authors. Published by Elsevier B.V. on behalf of King Saud University. This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).